RTRX
$20.89
Retrophin
$.33
1.61%
RTRX
Earnings Whisper ®
N/A
2nd Quarter June 2020
Consensus:  ($0.58)
Revenue:  $47.72 Mil
Monday
Aug 10
4:00 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when RTRX reports earnings?
Beat
Meet
Miss

Where is RTRX's stock price going from here?
Up
Flat
Down
Stock chart of RTRX
Analysts
Summary of analysts' recommendations for RTRX
Score
Grade
Pivots
Resistance
$22.26
$21.83
$21.36

$20.93

Support
$20.46
$20.03
$19.56
Tweet
Growth
Description
Retrophin, Inc. is a biopharmaceutical company. The Company focused on diseases which include Focal Segmental Glomerulosclerosis, Pantothenate Kinase-Associated Neurodegeneration, Duchenne Muscular Dystrophy and others. Retrophin, Inc. is based in New York.